These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 30471099)
1. Circulating visfatin levels and cancers risk: A systematic review and meta-analysis. Mohammadi M; Mianabadi F; Mehrad-Majd H J Cell Physiol; 2019 Apr; 234(4):5011-5022. PubMed ID: 30471099 [TBL] [Abstract][Full Text] [Related]
2. The Value of Visfatin in the Prediction of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Jiang Y; Zhou L Horm Metab Res; 2023 Sep; 55(9):610-616. PubMed ID: 36894154 [TBL] [Abstract][Full Text] [Related]
3. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies. Wei T; Ye P; Peng X; Wu LL; Yu GY Oncotarget; 2016 Jul; 7(30):48671-48691. PubMed ID: 27119501 [TBL] [Abstract][Full Text] [Related]
4. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis. Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis. Arjmand MH; Moradi A; Akbari A; Mehrad-Majd H Cytokine; 2020 Jan; 125():154869. PubMed ID: 31585311 [TBL] [Abstract][Full Text] [Related]
6. Association between circulating visfatin and pre-eclampsia: a systematic review and meta-analysis. Amiri-Dashatan N; Koushki M; Hosseini H; Khodabandehloo H; Fathi M; Doustimotlagh AH; Rezaei-Tavirani M J Matern Fetal Neonatal Med; 2022 Jul; 35(13):2606-2618. PubMed ID: 32635792 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review. Chen S; Wu K; Ke Y; Chen S; He R; Zhang Q; Shen C; Li Q; Ruan Y; Zhu Y; Du K; Hu J; Liu S Medicine (Baltimore); 2024 Sep; 103(37):e39613. PubMed ID: 39287295 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of visfatin in various human malignancies: A systematic review and meta-analysis. Mohammadi M; Moradi A; Farhadi J; Akbari A; Pourmandi S; Mehrad-Majd H Cytokine; 2020 Mar; 127():154964. PubMed ID: 31901760 [TBL] [Abstract][Full Text] [Related]
10. Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study. Qiu Y; Wang SF; Yu C; Chen Q; Jiang R; Pei L; Huang YL; Pang NZ; Zhang Z; Ling W; Yang L Ann Nutr Metab; 2019; 74(1):44-52. PubMed ID: 30541001 [TBL] [Abstract][Full Text] [Related]
11. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. Lee YH; Bae SC Int J Rheum Dis; 2018 Mar; 21(3):664-672. PubMed ID: 28205390 [TBL] [Abstract][Full Text] [Related]
12. High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis. Sun Y; Wu Z; Wei L; Liu C; Zhu S; Tang S Gynecol Endocrinol; 2015 Oct; 31(10):808-14. PubMed ID: 26422683 [TBL] [Abstract][Full Text] [Related]
13. Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients. Chen M; Wang Y; Li Y; Zhao L; Ye S; Wang S; Yu C; Xie H Asia Pac J Clin Oncol; 2016 Mar; 12(1):e65-74. PubMed ID: 23910020 [TBL] [Abstract][Full Text] [Related]
14. Association of circulating resistin, leptin, adiponectin and visfatin levels with Behçet disease: a meta-analysis. Lee YH; Song GG Clin Exp Dermatol; 2018 Jul; 43(5):536-545. PubMed ID: 29356069 [TBL] [Abstract][Full Text] [Related]
15. Increased Peripheral Blood Visfatin Concentrations May Be a Risk Marker of Coronary Artery Disease: A Meta-Analysis of Observational Studies. Yu F; Li J; Huang Q; Cai H Angiology; 2018 Oct; 69(9):825-834. PubMed ID: 29706084 [TBL] [Abstract][Full Text] [Related]
16. Impact of statin therapy on plasma resistin and visfatin concentrations: A systematic review and meta-analysis of controlled clinical trials. Sahebkar A; Giorgini P; Ludovici V; Pedone C; Ferretti G; Bacchetti T; Grassi D; Di Giosia P; Ferri C Pharmacol Res; 2016 Sep; 111():827-837. PubMed ID: 27468651 [TBL] [Abstract][Full Text] [Related]
17. Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review. Pace NP; Bonello A; Roshan MH; Vassallo J Minerva Ginecol; 2019 Aug; 71(4):329-343. PubMed ID: 31274262 [TBL] [Abstract][Full Text] [Related]
18. Circulating Clusterin Levels and Cancer Risk: A Systematic Review and Meta-Analysis. Beheshti Namdar A; Kabiri M; Mosanan Mozaffari H; Aminifar E; Mehrad-Majd H Cancer Control; 2022; 29():10732748211038437. PubMed ID: 35465749 [TBL] [Abstract][Full Text] [Related]
19. Association between visfatin and periodontitis: a systematic review and meta-analysis. Li Y; Xin C; Xie J; Sun X PeerJ; 2024; 12():e17187. PubMed ID: 38560458 [TBL] [Abstract][Full Text] [Related]
20. An elevated plasma level of visfatin increases the risk of myocardial infarction. Yang Y; Li Z; Tao HF; Qi XY; Wang WL; Yang L; Wang H; Xu P Genet Mol Res; 2014 Jan; 13(4):8586-95. PubMed ID: 24615088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]